Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-04-30

Clinical Trial Update: Transdermal Clonidine in the Treatment of Severe Hyperemesis Gravidarum [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating transdermal clonidine for severe hyperemesis gravidarum completed with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clonidine transdermal patch (clonidine)

Snippet

Sponsor: A.O.U. Città della Salute e della Scienza | Conditions: Hyperemesis Gravidarum | Phase 3 | Status: COMPLETED | Results posted: 2014-04-30